Saudi Arabia vs South America: Proportion of the target population who received a 3rd dose of
Saudi Arabia
96.0%
in 2024
South America
77.0%
in 2024
Saudi Arabia rank
16th
South America rank
16th
Proportion of the target population who received a 3rd dose of over time
- Saudi Arabia
- South America
How they compare
Saudi Arabia currently reports 96.0% against 77.0% in South America, a difference of 19.0%.
That makes Saudi Arabia's figure about 1.2 times South America's.
Across all 16 years both countries report, Saudi Arabia has been ahead every year.
Saudi Arabia ranks 16th and South America ranks 16th of 157 countries.
Saudi Arabia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Saudi Arabia | South America | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 98.0% | 1.0% | 97.0% | Saudi Arabia |
| 2010s | 97.8% | 69.8% | 28.0% | Saudi Arabia |
| 2020s | 96.6% | 71.6% | 25.0% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Saudi Arabia or South America?
- Saudi Arabia, at 96.0% against 77.0% in South America as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Saudi Arabia and South America?
- 19.0%, with Saudi Arabia ahead.
- How many years of comparable data are there for Saudi Arabia and South America?
- 16 years are reported by both, from 2009 to 2024.
- How do Saudi Arabia and South America rank globally for proportion of the target population who received a 3rd dose of?
- Saudi Arabia ranks 16th and South America ranks 16th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.